141 related articles for article (PubMed ID: 38095392)
1. The potential therapeutic effect of metformin in type 2 diabetic patients with severe COVID-19.
Al-Kuraishy HM; Al-Gareeb AI; El Kholy AA; El-Khateeb E; Alexiou A; Papadakis M; Elekhnawy E; Alsubaie N; Hamad RS; Batiha GE
Eur Rev Med Pharmacol Sci; 2023 Dec; 27(23):11445-11456. PubMed ID: 38095392
[TBL] [Abstract][Full Text] [Related]
2. Inpatient use of metformin and acarbose is associated with reduced mortality of COVID-19 patients with type 2 diabetes mellitus.
Li J; Wei Q; McCowen KC; Xiong W; Liu J; Jiang W; Thomas RL; Hepokoski M; He M; Shyy JYJ; Malhotra A; Xiong N; Li WX
Endocrinol Diabetes Metab; 2022 Jan; 5(1):e00301. PubMed ID: 34585841
[TBL] [Abstract][Full Text] [Related]
3. How are patients with type 2 diabetes and renal disease monitored and managed? Insights from the observational OREDIA study.
Penfornis A; Blicklé JF; Fiquet B; Quéré S; Dejager S
Vasc Health Risk Manag; 2014; 10():341-52. PubMed ID: 24966684
[TBL] [Abstract][Full Text] [Related]
4. Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study.
Pérez-Belmonte LM; Torres-Peña JD; López-Carmona MD; Ayala-Gutiérrez MM; Fuentes-Jiménez F; Jorge Huerta L; Muñoz JA; Rubio-Rivas M; Madrazo M; Garcia MG; Montes BV; Sola JF; Ena J; Ferrer RG; Pérez CM; Ripper CJ; Lecumberri JJN; Acedo IEA; Canteli SP; Cosío SF; Martínez FA; Rodríguez BC; Pérez-Martínez P; Ramos-Rincón JM; Gómez-Huelgas R;
BMC Med; 2020 Nov; 18(1):359. PubMed ID: 33190637
[TBL] [Abstract][Full Text] [Related]
5. The evaluation of clinical and cost outcomes associated with earlier initiation of insulin in patients with type 2 diabetes mellitus.
Smolen HJ; Murphy DR; Gahn JC; Yu X; Curtis BH
J Manag Care Spec Pharm; 2014 Sep; 20(9):968-84. PubMed ID: 25166296
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for COVID-19 case fatality rate in people with type 1 and type 2 diabetes mellitus: A nationwide retrospective cohort study of 235,248 patients in the Russian Federation.
Shestakova MV; Vikulova OK; Elfimova AR; Deviatkin AA; Dedov II; Mokrysheva NG
Front Endocrinol (Lausanne); 2022; 13():909874. PubMed ID: 36017317
[TBL] [Abstract][Full Text] [Related]
7. Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparison.
Wang JS; Lin SD; Lee WJ; Su SL; Lee IT; Tu ST; Tseng YH; Lin SY; Sheu WH
Clin Ther; 2011 Dec; 33(12):1932-42. PubMed ID: 22078152
[TBL] [Abstract][Full Text] [Related]
8. Mortality and other important diabetes-related outcomes with insulin vs other antihyperglycemic therapies in type 2 diabetes.
Currie CJ; Poole CD; Evans M; Peters JR; Morgan CL
J Clin Endocrinol Metab; 2013 Feb; 98(2):668-77. PubMed ID: 23372169
[TBL] [Abstract][Full Text] [Related]
9. Anti-Inflammatory Potential of the Anti-Diabetic Drug Metformin in the Prevention of Inflammatory Complications and Infectious Diseases Including COVID-19: A Narrative Review.
Plowman TJ; Christensen H; Aiges M; Fernandez E; Shah MH; Ramana KV
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791227
[TBL] [Abstract][Full Text] [Related]
10. Potential Therapeutic Benefits of Metformin Alone and in Combination with Sitagliptin in the Management of Type 2 Diabetes Patients with COVID-19.
Al-Kuraishy HM; Al-Gareeb AI; Albogami SM; Jean-Marc S; Nadwa EH; Hafiz AA; A Negm W; Kamal M; Al-Jouboury M; Elekhnawy E; Batiha GE; Waard M
Pharmaceuticals (Basel); 2022 Nov; 15(11):. PubMed ID: 36355535
[TBL] [Abstract][Full Text] [Related]
11. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
12. Non-insulin anti-diabetic agents in patients with type 2 diabetes and COVID-19: A Critical Appraisal of Literature.
Singh AK; Singh R; Saboo B; Misra A
Diabetes Metab Syndr; 2021; 15(1):159-167. PubMed ID: 33352455
[TBL] [Abstract][Full Text] [Related]
13. An economic evaluation of colesevelam when added to metformin-, insulin- or sulfonylurea-based therapies in patients with uncontrolled type 2 diabetes mellitus.
Simons WR; Hagan MA
Pharmacoeconomics; 2010; 28(9):765-80. PubMed ID: 20799756
[TBL] [Abstract][Full Text] [Related]
14. Metformin Use in Diabetes Prior to Hospitalization: Effects on Mortality in Covid-19.
Li J; Wei Q; Li WX; McCowen KC; Xiong W; Liu J; Jiang W; Marin T; Thomas RL; He M; Gongol B; Hepokoski M; Yuan JX; Shyy JY; Xiong N; Malhotra A
Endocr Pract; 2020 Oct; 26(10):1166-1172. PubMed ID: 33471718
[TBL] [Abstract][Full Text] [Related]
15. Effect of metformin and insulin combination on monocyte chemoattractant protein-1 and cathepsin-D in type 2 diabetes mellitus.
Kher M; Beri S; Rehan HS; Prakash A; Gupta LK
Diabetes Metab Syndr; 2020; 14(6):1703-1710. PubMed ID: 32911202
[TBL] [Abstract][Full Text] [Related]
16. A Prospective Analysis of the Efficacy and Safety of Sodium Glucose Cotransporter 2 Inhibitors: Real World Evidence from Clinical Practice in India.
Sosale B; Sosale AR; Kumar PM; Joshi SR
J Assoc Physicians India; 2016 Sep; 64(9):40-44. PubMed ID: 27762514
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effect of nano-selenium and metformin on type 2 diabetic rat model: Diabetic complications alleviation through insulin sensitivity, oxidative mediators and inflammatory markers.
Abdulmalek SA; Balbaa M
PLoS One; 2019; 14(8):e0220779. PubMed ID: 31442295
[TBL] [Abstract][Full Text] [Related]
18. Pharmacotherapeutic considerations for the management of diabetes mellitus among hospitalized COVID-19 patients.
Hasan SS; Kow CS; Bain A; Kavanagh S; Merchant HA; Hadi MA
Expert Opin Pharmacother; 2021 Feb; 22(2):229-240. PubMed ID: 33054481
[TBL] [Abstract][Full Text] [Related]
19. Effects of metformin, insulin on COVID-19 patients with pre-existed type 2 diabetes: A multicentral retrospective study.
Cheng X; Xin S; Chen Y; Li L; Chen W; Li W; Zhou B; Li C; Gong Y; Li F; Duan P; Zhou X
Life Sci; 2021 Jun; 275():119371. PubMed ID: 33745895
[TBL] [Abstract][Full Text] [Related]
20. The Efficacy and Potential Mechanisms of Metformin in the Treatment of COVID-19 in the Diabetics: A Systematic Review.
Zangiabadian M; Nejadghaderi SA; Zahmatkesh MM; Hajikhani B; Mirsaeidi M; Nasiri MJ
Front Endocrinol (Lausanne); 2021; 12():645194. PubMed ID: 33815295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
